Anti cancer drugs exposure anticancer drugs or radiation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Cell Line, Tumor Tumor Cells, Cultured Cell Line HCT116 Cells MCF-7 Cells HT29 Cells Cells, Cultured Neoplastic Stem Cells HeLa Cells

Organisms4

Mice, Nude Mice, Inbred BALB C Mice, SCID Mice, Inbred C57BL

Diseases39

Neoplasms Radiation Injuries Breast Neoplasms Prostatic Neoplasms Colonic Neoplasms Ovarian Neoplasms Lung Neoplasms Neoplasms, Radiation-Induced Radiation Injuries, Experimental Stomach Neoplasms Neoplasm Metastasis Radiation Pneumonitis Pancreatic Neoplasms Neoplasm Invasiveness Prenatal Exposure Delayed Effects Carcinoma, Squamous Cell Adenocarcinoma Neoplasms, Experimental Carcinoma, Non-Small-Cell Lung Carcinoma Uterine Cervical Neoplasms Brain Neoplasms Head and Neck Neoplasms Disease Progression Colorectal Neoplasms Neoplasm Recurrence, Local Urinary Bladder Neoplasms Cell Transformation, Neoplastic Disease Models, Animal Leukemia L1210 Genetic Predisposition to Disease Liver Neoplasms Drug-Related Side Effects and Adverse Reactions Neovascularization, Pathologic Rectal Neoplasms Drug-Induced Liver Injury, Chronic Acute Radiation Syndrome Melanoma Skin Neoplasms

Chemicals and Drugs75

Antineoplastic Agents Doxorubicin Cisplatin Antineoplastic Agents, Phytogenic Drug Carriers Drugs, Investigational Antibiotics, Antineoplastic P-Glycoprotein Neoplasm Proteins Enzyme Inhibitors Paclitaxel Protein Kinase Inhibitors Pyrimidines Naphthoquinones Fluorouracil Etoposide Camptothecin Radiation-Sensitizing Agents Piperazines Tumor Markers, Biological Antimetabolites, Antineoplastic DNA, Neoplasm RNA, Messenger Tumor Suppressor Protein p53 DNA Prodrugs Plant Extracts Ellipticines Platinum Organoplatinum Compounds Daunorubicin RNA, Small Interfering Benzamides Cocaine Cancer Vaccines Antibodies, Monoclonal Mitomycin Deoxycytidine Angiogenesis Inhibitors Anticarcinogenic Agents Antineoplastic Agents, Alkylating Proto-Oncogene Proteins c-abl DNA Adducts Radiation-Protective Agents Proto-Oncogene Proteins c-bcl-2 DNA-Binding Proteins Caspases Caspase 3 Topoisomerase I Inhibitors Receptor, erbB-2 Topotecan DNA Topoisomerases, Type II Indoles Quinazolines Triazines Taxoids Carboplatin Antigens, Neoplasm Tumor Suppressor Proteins Vincristine Nanocapsules Receptors, Estrogen Vinblastine Receptor, Epidermal Growth Factor Methotrexate Mitoxantrone Protein-Serine-Threonine Kinases Prostate-Specific Antigen Pharmaceutical Preparations Pyridines Cyclophosphamide Tamoxifen Mitomycins Cobalt Radioisotopes Thiazoles

Analytical, Diagnostic and Therapeutic Techniques and Equipment62

Drug Screening Assays, Antitumor Radiation Dosage Dose-Response Relationship, Radiation Drug Design Drug Delivery Systems Drug Discovery Molecular Targeted Therapy Xenograft Model Antitumor Assays Radiation Monitoring Drug Carriers Inhibitory Concentration 50 Drug Approval Clinical Trials as Topic Early Detection of Cancer Drug Evaluation, Preclinical Models, Biological Combined Modality Therapy Blotting, Western Radiotherapy Antineoplastic Combined Chemotherapy Protocols Area Under Curve Gene Expression Profiling Radiation Injuries, Experimental Models, Molecular Radiotherapy Dosage Drug Administration Schedule Neoplasm Transplantation Treatment Outcome Retrospective Studies Reverse Transcriptase Polymerase Chain Reaction Neoplasms, Experimental Follow-Up Studies Radiometry Survival Analysis Tumor Stem Cell Assay Prospective Studies Transplantation, Heterologous Survival Rate Prognosis Flow Cytometry Tumor Burden Administration, Oral Neoplasm Staging Risk Assessment Risk Factors Transfection Disease-Free Survival Disease Models, Animal Risk Radiotherapy, Adjuvant Reproducibility of Results Metabolic Clearance Rate Magnetic Resonance Spectroscopy Chromatography, High Pressure Liquid Chemotherapy, Adjuvant Sensitivity and Specificity Phytotherapy Dose Fractionation Oligonucleotide Array Sequence Analysis Nanocapsules Registries Polymerase Chain Reaction

Phenomena and Processes58

Radiation Dosage Radiation, Ionizing Drug Resistance, Neoplasm Dose-Response Relationship, Radiation Radiation Tolerance Cell Survival Apoptosis Radiation Dose-Response Relationship, Drug Cell Proliferation Drug Resistance, Multiple Inhibitory Concentration 50 Gene Expression Regulation, Neoplastic Cell Cycle Molecular Structure Time Factors DNA Damage Drug Synergism Signal Transduction Area Under Curve Gamma Rays Cosmic Radiation Structure-Activity Relationship Cell Division Mutation Ultraviolet Rays Background Radiation Drug Resistance DNA Repair Down-Regulation Drug Interactions Radiation Effects Base Sequence Protein Binding DNA Adducts Transfection Pregnancy Tissue Distribution Risk Genetic Predisposition to Disease Kinetics Cell Death Cell Growth Processes Stereoisomerism Metabolic Clearance Rate Phosphorylation Up-Regulation RNA Interference Sensitivity and Specificity Gene Expression Genotype X-Rays Phenotype Half-Life Genes, p53 Cell Movement Protein Structure, Tertiary Promoter Regions, Genetic

Disciplines and Occupations7

Drug Design Drug Discovery Radiation Oncology Medical Oncology Nanomedicine Pharmacoepidemiology Radiobiology

Anthropology, Education, Sociology and Social Phenomena3

Drug Approval United States Food and Drug Administration National Cancer Institute (U.S.)

Technology, Industry, Agriculture4

Drug Industry Nanoparticles Nanomedicine Nanocapsules

Information Science5

Pharmacopoeias as Topic Survival Rate Molecular Sequence Data Base Sequence Registries

Named Groups1

Health Care32

Radiation Dosage Radiation Injuries Dose-Response Relationship, Radiation Radiation Protection Radiation Monitoring Clinical Trials as Topic Drug Costs United States Food and Drug Administration Fees, Pharmaceutical Area Under Curve Cosmic Radiation Radiation Injuries, Experimental Cost Sharing Treatment Outcome Retrospective Studies Ultraviolet Rays Follow-Up Studies Survival Analysis National Cancer Institute (U.S.)Prospective Studies Survival Rate Radiation Effects Risk Assessment Risk Factors Disease-Free Survival Risk Age Factors Reproducibility of Results Sensitivity and Specificity Acute Radiation Syndrome Registries Radioactive Hazard Release

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care Geographicals

Antineoplastic Agents Neoplasms Drug Screening Assays, Antitumor Radiation Dosage Radiation, Ionizing Drug Resistance, Neoplasm Cell Line, Tumor Radiation Injuries Dose-Response Relationship, Radiation Radiation Tolerance Cell Survival Apoptosis Drug Design Drug Delivery Systems Drug Discovery Doxorubicin Radiation Cisplatin Breast Neoplasms Dose-Response Relationship, Drug Molecular Targeted Therapy Mice, Nude Radiation Protection Xenograft Model Antitumor Assays Cell Proliferation Tumor Cells, Cultured Radiation Monitoring Antineoplastic Agents, Phytogenic Drug Carriers Drug Resistance, Multiple Inhibitory Concentration 50 Gene Expression Regulation, Neoplastic Drug Approval Clinical Trials as Topic Prostatic Neoplasms Drugs, Investigational Cell Cycle Antibiotics, Antineoplastic Molecular Structure P-Glycoprotein Colonic Neoplasms Early Detection of Cancer Drug Evaluation, Preclinical Neoplasm Proteins Time Factors Ovarian Neoplasms DNA Damage Radiation Oncology Lung Neoplasms Drug Industry Enzyme Inhibitors Models, Biological Paclitaxel Medical Oncology Protein Kinase Inhibitors Neoplasms, Radiation-Induced Combined Modality Therapy Drug Costs Drug Synergism Blotting, Western United States Food and Drug Administration Signal Transduction Radiotherapy Fees, Pharmaceutical Antineoplastic Combined Chemotherapy Protocols Pyrimidines Naphthoquinones Area Under Curve Fluorouracil United States Gamma Rays Etoposide Camptothecin Cosmic Radiation Gene Expression Profiling Radiation Injuries, Experimental Models, Molecular Radiation-Sensitizing Agents Piperazines Stomach Neoplasms Neoplasm Metastasis Tumor Markers, Biological Radiation Pneumonitis Structure-Activity Relationship Pancreatic Neoplasms Cell Division Cost Sharing Antimetabolites, Antineoplastic DNA, Neoplasm RNA, Messenger Radiotherapy Dosage Drug Administration Schedule Pharmacopoeias as Topic Tumor Suppressor Protein p53 Neoplasm Invasiveness Neoplasm Transplantation Mutation DNA Treatment Outcome Prenatal Exposure Delayed Effects

No FAQ available that match "anti cancer drugs exposure anticancer drugs or radiation"